Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
AMGN News
Amgen (AMGN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on May 2. Analyst David Risinger from Leerink Partners mai...
Goldman Sachs analyst Salveen Richter maintained a Buy rating on Amgen (AMGN – Research Report) on May 1 and set a price target of $400.00. Salveen Richter has...
Amgen Inc. AMGN reported first-quarter sales of $8.15 billion on Thursday, up 9% year over year and beating the consensus of $8.06 billion. Product sales grew...
Analyst ratings
50%
of 32 ratingsMore AMGN News
recently reported strong financial results for Q1 2025, showing a turnaround from a loss to a substantial net income. This positive performance included ambitio...
UBS analyst Trung Huynh lowered the firm’s price target on Amgen (AMGN) to $315 from $319 and keeps a Neutral rating on the shares. The firm notes a “strong” op...
TD Cowen analyst Yaron Werber maintained a Buy rating on Amgen (AMGN – Research Report) yesterday and set a price target of $389.00. Yaron Werber has given his...
Reports Q1 revenue $8.1B, consensus $8.04B. “Demand for our products was strong globally in the first quarter. Ongoing new product launches and successful Phase...
Amgen (NASDAQ:AMGN) is set to report its Q1 earnings results on Thursday, May 1st, after the market closes. Street Expectations Analysts expect the biotech fi...
